다음과 같은 기능을 한번의 로그인으로 사용 할 수 있습니다.
NTIS 바로가기
Neurotoxicology and teratology, v.22 no.6, 2000년, pp.799 - 804
Crawford, Cynthia A (Corresponding author. Tel.: +1-909-880-7416) , Zavala, Arturo R (fax: +1-909-880-7003) , Karper, Patrick E (Department of Psychology, California State University, 5500 University Parkway, San Bernardino, CA 92407-2397, USA) , McDougall, Sanders A (Department of Psychology, California State University, 5500 University Parkway, San Bernardino, CA 92407-2397, USA)
AI-Helper
AbstractThe purpose of the present study was to determine whether exposure to amphetamine during the preweanling period would alter dopaminergic functioning in the dorsal striatum of adult rats. In three experiments, we assessed the effects of repeated amphetamine treatment on striatal protein kinas...
J. Pharmacol. Exp. Ther. Barnett 242 40 1987 Repeated amphetamine pretreatment alters the responsiveness of striatal dopamine-stimulated adenylate cyclase to amphetamine-induced desensitization
Neurosci. Biobehav. Rev. Beninger 22 335 1998 10.1016/S0149-7634(97)00019-5 Dopamine D1-like receptors and reward-related incentive learning
J. Neurosci. Boyson 6 3177 1986 10.1523/JNEUROSCI.06-11-03177.1986 Quantitative autoradiographic localization of the D1 and D2 subtypes of dopamine receptors in rat brain
Anal. Biochem. Bradford 72 248 1976 10.1016/0003-2697(76)90527-3 A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding
J. Pharmacol. Exp. Ther. Clausing 274 614 1995 Amphetamine levels in brain microdialysate, caudate/putamen, substantia nigra and plasma after dosage that produces either behavioral or neurotoxic effects
C.A. Crawford, A.R. Zavala, P.E. Karper, R.L. Collins, T.L. Meier, J.B. Watson, S.A. McDougall, Amphetamine treatment during the preweanling period produces long-term changes in striatal protein kinase A activity, Pharmacol., Biochem. Behav. (in press).
Neurotoxicol. Teratol. Dow-Edwards 20 133 1998 10.1016/S0892-0362(97)00095-0 Preweaning cocaine administration alters the adult response to quipazine: Comparison with fluoxetine
Pharmacol., Biochem. Behav. Fields 40 881 1991 10.1016/0091-3057(91)90101-7 Long-lasting dopamine receptor up-regulation in amphetamine-treated rats following amphetamine neurotoxicity
Dev. Brain Res. Frick 88 158 1995 10.1016/0165-3806(95)00094-T The effects of cocaine on cerebral metabolic function in periweanling rats: The roles of serotonergic and dopaminergic uptake blockade
Gibb 269 1994 Amphetamine and Its Analogs: Pharmacology, Toxicology, and Abuse Neurochemical mechanisms of toxicity
NIDA Res. Monogr. Gibb 173 128 1997 Neurotoxicity of amphetamine and their metabolites
Life Sci. Huang 61 2219 1997 10.1016/S0024-3205(97)00924-7 Amphetamine induces hydroxyl radical formation in the striatum of rats
J. Am. Acad. Child Adolesc. Psychiatry Jacobvitz 29 677 1990 10.1097/00004583-199009000-00001 Treatment of attentional and hyperactivity problems in children with sympathomimetic drugs: A comprehensive review
Eur. J. Pharmacol. Johansson 269 149 1994 10.1016/0922-4106(94)90081-7 Forskolin-induced up-regulation and functional supersensitivity of dopamine D2 long receptors expressed by Ltk− cells
Exp. Neurol. Joyce 113 261 1991 10.1016/0014-4886(91)90016-6 Differential responses of striatal dopamine and muscarinic cholinergic receptor subtypes to the loss of dopamine: I. Effects of intranigral or intracerebroventricular 6-hydroxydopamine lesions of the mesostriatal dopamine systems
Nature Kebabian 277 93 1979 10.1038/277093a0 Multiple receptors for dopamine
Kirk 237 1982 Experimental Design
Brain Res. Kleven 532 265 1990 10.1016/0006-8993(90)91768-C Effects of repeated injections of cocaine on D1 and D2 dopamine receptors in rat brain
Kuczenski 81 1994 Amphetamine and its Analogs: Pharmacology, Toxicology, and Abuse Neurochemistry of amphetamine
J. Neurochem. 68 2032 1997 10.1046/j.1471-4159.1997.68052032.x Effects of methylphenidate on extracellular dopamine, serotonin, and norepinephrine: Comparison with amphetamine
Brain Res. Marshall 493 247 1989 10.1016/0006-8993(89)91160-8 Decreased striatal D1 binding density following mesotelencephalic 6-hydroxydopamine injections: An autoradiographic analysis
Exp. Clin. Psychopharmacol. McDougall 7 208 1999 10.1037/1064-1297.7.3.208 Effects of repeated methylphenidate treatment in the young rat: Sensitization of both locomotor activity and stereotyped sniffing
Cell. Mol. Life Sci. Micheau 55 534 1999 10.1007/s000180050312 Protein kinases: Which one is the memory molecule?
Science Nestler 278 58 1997 10.1126/science.278.5335.58 Molecular and cellular basis of addiction
Brain Res. Ricaurte 303 359 1984 10.1016/0006-8993(84)91221-6 Further evidence that amphetamines produce long-lasting dopamine neurochemical deficits by destroying dopamine nerve terminals
Neurochem. Int. Richtand 31 131 1997 10.1016/S0197-0186(96)00097-6 Quantification of dopamine D1 and D2 receptor mRNA levels associated with the development of behavioral sensitization in amphetamine treated rats
Brain Res. Robertson 267 179 1983 10.1016/0006-8993(83)91055-7 Chronic D-amphetamine and phencyclidine: Effects on dopamine agonist and antagonist binding sites in the extrapyramidal and mesolimbic systems
Brain Res. Rev. Robinson 11 157 1986 10.1016/0165-0173(86)90002-0 Enduring changes in brain and behavior produced by chronic amphetamine administration: A review and evaluation of animal models of amphetamine psychosis
J. Pharmacol. Exp. Ther. Roseboom 255 197 1990 Repeated amphetamine administration alters the interaction between D1-stimulated adenylyl cyclase activity and calmodulin in rat striatum
J. Neurochem. Schettini 59 1667 1992 10.1111/j.1471-4159.1992.tb10997.x Modulation by GTP of basal and agonist-stimulated striatal adenylate cyclase activity following chronic blockade of D1 and D2 dopamine receptors: Involvement of G proteins in the development of receptor supersensitivity
Eur. J. Pharmacol. Shi 370 241 1999 10.1016/S0014-2999(99)00110-7 Chronic haloperidol alters dopamine receptors: Effects of cocaine exposure during the preweanling period
Trends Pharmacol. Sci. Sibley 68 97 1992 Molecular biology of dopamine receptors
J. Am. Acad. Child Adolesc. Psychiatry Spencer 35 409 1996 10.1097/00004583-199604000-00008 Pharmacotherapy of attention-deficit hyperactivity disorder across the life cycle
Neurotoxicol. Teratol. Vorhees 22 255 2000 10.1016/S0892-0362(99)00071-9 Evaluation of neonatal exposure to cocaine on learning, activity, startle, scent marking, immobility, and plasma cocaine concentrations
Neurology Wagner 30 547 1980 10.1212/WNL.30.5.547 Amphetamine induces depletion of dopamine and loss of dopamine uptake sites in caudate
Pharmacol. Rev. Walaas 43 299 1991 Protein phosphorylation and neuronal function
Cell. Mol. Neurobiol. Wanderoy 17 547 1997 10.1023/A:1026367023458 Molecular mechanisms underlying forskolin-mediated up-regulation of human dopamine D2L receptors
NeuroReport Wanderoy 8 2971 1997 10.1097/00001756-199709080-00033 Dopamine D2 receptor upregulation in rat neostriatum following in vivo infusion of forskolin
Psychiatr. Clin. North Am. Wilens 15 191 1992 10.1016/S0193-953X(18)30265-X The stimulants
Pediatrics Wolraich 86 95 1990 10.1542/peds.86.1.95 Stimulant medication use by primary care physicians in the treatment of attention deficit hyperactivity disorder
*원문 PDF 파일 및 링크정보가 존재하지 않을 경우 KISTI DDS 시스템에서 제공하는 원문복사서비스를 사용할 수 있습니다.
Copyright KISTI. All Rights Reserved.
※ AI-Helper는 부적절한 답변을 할 수 있습니다.